(VCYT:Consolidated Issue listed on NASDAQ Global Market)
Paul W. Ladenson M.D.
Member of Clinical Advisory Board, Veracyte, Inc.
|Age||Total Calculated Compensation||This person is connected to 14 board members in 1 different organizations across 1 different industries.|
See Board Relationships
Mr. Paul W. Ladenson, MD serves as the Editor-In-Chief at the Journal of Clinical Endocrinology and Metabolism. Mr. Ladenson serves as Director of the Division of Endocrinology and Metabolism and as Professor of Medicine, Pathology, Oncology, and Radiation at the Johns Hopkins University School of Medicine. He is a Distinguished University Professor at Johns Hopkins. Mr. Ladenson served as President of the American Thyroid Association. Mr. Ladenson served as Member of ...
7000 Shoreline CourtPhone: 650-243-6300
South San Francisco, California 94080
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|David P. King||Chairman and Chief Executive Officer|
Laboratory Corp. of America Holdings
|Kenneth A. Berlin||Chief Executive Officer and President|
Rosetta Genomics, Ltd.
|Kimberly J. Popovits||Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee|
Genomic Health Inc.
|Thomas A. Bologna||Chairman and Chief Executive Officer|
Response Genetics, Inc
|Antonius P. Schuh Ph.D.||Chief Executive Officer and Director|
|$539.0K||Compensation as of Fiscal Year 2014.|